Related Experiment Video
Updated: Jun 4, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Siligraphene as targeted carrier for 5-FU anticancer drug delivery with smart release: A first-principles study
Marey Almaghrabi1, Abdulsalam Q Almashhadani2, Ghada Al-Assi3
1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Taibah University, Madinah, Saudi Arabia.
None:
The investigation of the extended drug release of the 5-fluorouracil (5FU) molecule through a g-SiC₂ sheet has become a significant area of interest with the emergence of novel nanomaterials. The present study utilizes density functional theory to explore the potential for controlled and sustained drug delivery. The calculations involved the assessment of topological and electronic properties, charge transfer (CT), adsorption energies (Eads), and the release behavior of 5FU@g-SiC₂. The most stable configuration exhibited Eads of -1.624 eV. To comprehensively evaluate the interaction characteristics of the anticancer drug 5FU on g-SiC₂, the study examined electronic features, charge distributions, and frontier molecular orbitals. In addition, natural bond orbital (NBO) analysis indicated charge transfer from the 5FU molecule to g-SiC₂. Solvent effects were found to reduce the binding energy of 5FU in the 5FU@g-SiC₂ complex. The findings suggest that 5FU may undergo protonation in tumor tissues, thereby facilitating the release of the drug from the g-SiC₂ surface.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
